Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
11 - 20 out of 20Page size: 10
  1. 2016
  2. Published

    Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

    Hegen, H., Adrianto, I., Lessard, C. J., Millonig, A., Bertolotto, A., Comabella, M., Giovannoni, G., Guger, M., Hoelzl, M., Khalil, M., Fazekas, F., Killestein, J., Lindberg, R. L. P., Malucchi, S., Mehling, M., Montalbán, X., Rudzki, D., Schautzer, F., Sellebjerg, F., Sorensen, P. S. & 3 others, Deisenhammer, F., Steinman, L. & Axtell, R. C., Apr 2016, In: Neurology: Neuroimmunology & Neuroinflammation. 3, 2, 11 p., e202.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Association between age at onset of multiple sclerosis and vitamin D level-related factors

    Laursen, J. H., Søndergaard, H. B., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A. B., 5 Jan 2016, In: Neurology. 86, 1, p. 88-93 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

    Hermanrud, C., Ryner, M., Luft, T., Jensen, P. E., Ingenhoven, K., Rat, D., Deisenhammer, F., Sørensen, Per Soelberg, Pallardy, M., Sikkema, D., Bertotti, E., Kramer, D., Creeke, P. & Fogdell-Hahn, A., 2016, In: Journal of Immunological Methods. 430, p. 1-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

    Sørensen, Per Soelberg, 2016, In: Multiple Sclerosis. 22, 10, p. 1260-1263 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort

    Thormann, A., Koch-Henriksen, N., Laursen, B., Sørensen, Per Soelberg & Magyari, M., 2016, In: Multiple Sclerosis and Related Disorders. 10, p. 181-186 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

    Ratzer, R., Iversen, P., Börnsen, L., Dyrby, T. B., Christensen, J. R., Ammitzbøll, C., Madsen, C. G., Garde, Ellen, Lyksborg, M., Andersen, B., Hyldstrup, L., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2016, In: Multiple Sclerosis Journal. 22, 7, p. 926–934 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Multiple sclerosis: Generic glatiramer acetate-a step toward cheaper MS drugs?

    Sørensen, Per Soelberg, 2016, In: Nature Reviews. Neurology. 12, 1, p. 5-6 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  9. Published

    Neurofilament in CSF—A biomarker of disease activity and long-term prognosis in multiple sclerosis

    Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2016, In: Multiple Sclerosis. 22, 9, p. 1112-1113 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  10. Published

    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

    Bachelet, D., Hässler, S., Mbogning, C., Link, J., Ryner, M., Ramanujam, R., Auer, M., Jensen, P. E. H., Koch-Henriksen, N., Warnke, C., Ingenhoven, K., Buck, D., Grummel, V., Lawton, A., Donnellan, N., Hincelin-Mery, A., Sikkema, D., Pallardy, M., Kieseier, B., Hemmer, B. & 8 others, Hartung, H. P., Sørensen, Per Soelberg, Deisenhammer, F., Dönnes, P., Davidson, J., Fogdell-Hahn, A., Broët, P. & ABIRISK Consortium, A. C., 2016, In: P L o S One. 11, 11, p. 1-19 19 p., e0162752.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    The potential role for ocrelizumab in the treatment of multiple sclerosis: Current evidence and future prospects

    Sørensen, Per Soelberg & Blinkenberg, M., 2016, In: Therapeutic Advances in Neurological Disorders. 9, 1, p. 44-52 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 Next

ID: 11025